Pharmacological inhibition of CB1R attenuates proliferation and tumor growth, inducing apoptosis and cell cycle arrest in breast cancer through upregulation of p27KIP1 and downregulation of cyclin D and E [167]. Here, CDKN1B is linked to breast cancer.